Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury

NCT05624203 is registered in ClinicalTrials.gov with First Affiliated Hospital of Kunming Medical University as lead sponsor.

NCT NCT05624203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05624203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury
Lead sponsor
First Affiliated Hospital of Kunming Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 30, 2024
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial reperfusion injury, prognosis, st elevation myocardial infarction, treatment outcome